Advances in pheochromocytoma management in the era of laparoscopy

Journal of Endourology

Volumn 21, Issue 11, 2007, Pages 1303-1307

  Faria, Eliney F ^a   Andreoni, Cassio ^a,b   Krebs, Rodrigo K ^a   Nascimento, Humberto ^a   Goldman, Susan M ^a   Kater, Claudio ^a   Ortiz, Valdemar ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL DISEASE; ADRENAL TUMOR; ADRENALECTOMY; ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLEEDING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; INTENSIVE CARE UNIT; LAPAROSCOPY; MALE; MEDICAL RECORD REVIEW; OPERATION DURATION; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAFETY; SURGICAL TECHNIQUE;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADULT; AGED; FEMALE; HUMANS; INTENSIVE CARE UNITS; LAPAROSCOPY; LENGTH OF STAY; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; PROSPECTIVE STUDIES;

EID: 36549021033     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2007.9884     Document Type: Article

References (19)

1. Anderson GH Jr, Blakeman N, Streeten DH. The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 1994;12:609-615.
2. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 2004;27:193-202.
3. Sinclair AM, Isles CG, Brown I, Cameron H, Murray GD, Robertson JW, Secondary hypertension in a blood pressure clinic. Arch Intern Med 1987;147:1289-1293.
4. Platts JK, Drew PJ, Harvey JN. Death from phaeochromocytoma: lessons from a post-mortem survey. J R Coll Physicians Lond 1995;29:299-306.
5. McNeil AR, Blok BH, Koelmeyer TD, Burke MP, Hilton JM. Phaeochromocytoma discovered during coronial autopsies in Sydney, Melbourne and Auckland. Aust N Z J Med 2000;30:648-652.
6. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 2005;366:665-675.
7. Schurmeyer TH, Engeroff B, Dralle H, von zur Muhlen A. Cardiological effects of catecholamine-secreting tumors. Eur J Clin Invest 1997;27:189-195.
8. Liao WB, Liu CF, Chiang CW, Kung CT, Lee CW. Cardiovascular manifestations of pheochromocytoma. Am J Emerg Med 2000;18:622-625.
9. Brouwers FM, Lenders JW, Eisenhofer G, Pacak K. Pheochromocytoma as an endocrine emergency. Rev Endocr Metab Disord 2003;4:121-128.
10. Baguet JP, Hammer L, Mazzuco TL, Chabre O, Mallion JM, Sturm N, Chaffanjon P. Circumstances of discovery of phaemochromocytoma: A retrospective study of 41 consecutive patients. Eur J Endocrinol 2004;150:681-686.
11. Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR. The clinically inapparent adrenal mass: Update in diagnosis and management. Endocr Rev 2004;25:309-340.
12. Lenders JW, Eisenhofer G, Armando I, Keiser HR, Goldstein DS, Kopin IJ. Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clin Chem 1993;39:97-103.
13. Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS. Recent advances in genetics, diagnosis, localization, and treatment of pheochromoctoma. Ann Intern Med 2001;134:315-329.
14. Ilias I, Pacak K. Current approaches and recommend algorithm for the diagnostic localization of pheochromocytoma. J Clin Endocrinol Metab 2004;89:479-491.
15. Gill IS. The case for laparoscopic adrenalectomy. J Urol 2001;166:429-436.
16. Kinney MA, Warner ME, van Heerden JA. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection. Anesth Analg 2000;91:1118-1123.
17. Quezado ZN, Keiser HR, Parker MM. Reversible myocardial depression after massive cathecolamine release from a pheochromocytoma. Crit Care Med 1992;20:549-551.
18. Averbuch SD, Steakley CS, Young RC, Gelmann EP, Goldstein DS, Stull R, Keiser HR. Malignant pheochromocytoma: Effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Intern Med 1988;109:267-273.
19. Rose B, Matthay KK, Price D, Huberty J, Klencke B, Norton JA, Fitzgerald PA. High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma. Cancer 2003;98:239-248.